Capstone Investment Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,767
Closed -$462K 2142
2024
Q1
$462K Buy
+5,767
New +$514K ﹤0.01% 1604
2021
Q4
Sell
-1,887
Closed -$247K 1875
2021
Q3
$247K Buy
+1,887
New +$247K ﹤0.01% 1659

Other funds holding CNMD

Capstone Investment Advisors's CNMD Position: Q2 2024 in Review

Capstone Investment Advisors sold out of CONMED (CNMD) in Q2 2024, closing a stake of 5,767 shares — an estimated $462K sold.

Capstone Investment Advisors first reported a position in CNMD in Q3 2021 and held it in 2 quarters. The position peaked at $462K in Q1 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Capstone Investment Advisors reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 5,767 CONMED shares in Q2 2024, an estimated $462K.
  • Capstone Investment Advisors first reported a position in CONMED in Q3 2021 and held it in 2 quarters.
  • Capstone Investment Advisors's CONMED position peaked at $462K in Q1 2024.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.